Hepatitis C Virus (HCV) diagnosis and access to treatment in a UK cohort
Background: As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate goal of e...
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Опубліковано: |
BioMed Central
2018
|